drugset
drugset / Trial / NCT05035641

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

NCT05035641 ↗

Phase 2 Completed 113 enrolled Kind Pharmaceuticals LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Timeline

Start
2021-10-18
Primary completion
2023-07-05
Completion
2023-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject AND017 Unknown — Oral

Indications

anemia